Corbus Pharmaceuticals Holdings (LTS:0SZI) Market Cap : $183.67 Mil (As of Dec. 13, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Corbus Pharmaceuticals Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Corbus Pharmaceuticals Holdings's share price for the quarter that ended in Sep. 2024 was $20.8623. Corbus Pharmaceuticals Holdings's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 12.18 Mil. Therefore, Corbus Pharmaceuticals Holdings's market cap for the quarter that ended in Sep. 2024 was $254.09 Mil.

Corbus Pharmaceuticals Holdings's quarterly market cap increased from Mar. 2024 ($417.88 Mil) to Jun. 2024 ($514.82 Mil) but then declined from Jun. 2024 ($514.82 Mil) to Sep. 2024 ($254.09 Mil).

Corbus Pharmaceuticals Holdings's annual market cap declined from Dec. 2021 ($81.49 Mil) to Dec. 2022 ($13.26 Mil) but then increased from Dec. 2022 ($13.26 Mil) to Dec. 2023 ($27.43 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Corbus Pharmaceuticals Holdings's Enterprise Value for Today is $27.92 Mil.

Corbus Pharmaceuticals Holdings Market Cap Historical Data

The historical data trend for Corbus Pharmaceuticals Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corbus Pharmaceuticals Holdings Market Cap Chart

Corbus Pharmaceuticals Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

323.36

124.55

81.49

13.26

27.43

Corbus Pharmaceuticals Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Market Cap	Get a 7-Day Free Trial															30.01	27.43	417.88	514.82	254.09

Competitive Comparison of Corbus Pharmaceuticals Holdings's Market Cap

For the Biotechnology subindustry, Corbus Pharmaceuticals Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Corbus Pharmaceuticals Holdings's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Corbus Pharmaceuticals Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Corbus Pharmaceuticals Holdings's Market Cap falls into.

Corbus Pharmaceuticals Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Corbus Pharmaceuticals Holdings's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	$6.2	*	4.42368
	=	$27.43

Corbus Pharmaceuticals Holdings's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )	=	Share Price (Q: Sep. 2024 )	*	Shares Outstanding (EOP) (Q: Sep. 2024 )
	=	$20.8623	*	12.1795
	=	$254.09

Corbus Pharmaceuticals Holdings (LTS:0SZI) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Corbus Pharmaceuticals Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of Corbus Pharmaceuticals Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Corbus Pharmaceuticals Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corbus Pharmaceuticals Holdings Inc (LTS:0SZI) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

CRBP:USA 3371:Germany

Address

500 River Ridge Drive, Norwood, MA, USA, 02062

Website

https://www.corbuspharma.com

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Corbus Pharmaceuticals Holdings Headlines

No Headlines